- Home
- STOK vs AMC Comparison
STOK vs AMC Comparison
Compare STOK & AMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STOK
- AMC
- Stock Information
- Founded
- STOK 2014
- AMC 1920
- Country
- STOK United States
- AMC United States
- Employees
- STOK N/A
- AMC N/A
- Industry
- STOK Biotechnology: Pharmaceutical Preparations
- AMC Movies/Entertainment
- Sector
- STOK Health Care
- AMC Consumer Discretionary
- Exchange
- STOK Nasdaq
- AMC Nasdaq
- Market Cap
- STOK 1.3B
- AMC 1.3B
- IPO Year
- STOK 2019
- AMC 2013
- Fundamental
- Price
- STOK $23.19
- AMC $2.42
- Analyst Decision
- STOK Strong Buy
- AMC Hold
- Analyst Count
- STOK 9
- AMC 6
- Target Price
- STOK $31.00
- AMC $3.43
- AVG Volume (30 Days)
- STOK 1.4M
- AMC 28.2M
- Earning Date
- STOK 11-04-2025
- AMC 11-05-2025
- Dividend Yield
- STOK N/A
- AMC N/A
- EPS Growth
- STOK N/A
- AMC N/A
- EPS
- STOK 0.68
- AMC N/A
- Revenue
- STOK $205,632,000.00
- AMC $4,867,000,000.00
- Revenue This Year
- STOK $416.54
- AMC $7.97
- Revenue Next Year
- STOK N/A
- AMC $6.77
- P/E Ratio
- STOK $33.39
- AMC N/A
- Revenue Growth
- STOK 1128.17
- AMC 9.74
- 52 Week Low
- STOK $5.35
- AMC $2.39
- 52 Week High
- STOK $38.69
- AMC $5.56
- Technical
- Relative Strength Index (RSI)
- STOK 33.50
- AMC 33.62
- Support Level
- STOK $20.32
- AMC $2.49
- Resistance Level
- STOK $33.88
- AMC $2.64
- Average True Range (ATR)
- STOK 2.07
- AMC 0.12
- MACD
- STOK -1.56
- AMC -0.02
- Stochastic Oscillator
- STOK 18.78
- AMC 5.66
About STOK Stoke Therapeutics Inc.
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
About AMC AMC Entertainment Holdings Inc.
AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. It owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.